🏢 官网IRCDNADoubao · 实盘不做把握 9/10不做原因:不是事件
北京时间·🕒 发布 04:01:00(美东 10-15 16:01)·⟳ 抓取 04:08:29回填·⚡ 决策 10-16 04:09:42·11.9 天前
CareDx（CDNA）宣布将于2026年10月29日盘后公布三季报，仅为财报日期通知
这是上市公司每季例行的财报日期预告（date-of-earnings notice），全文只有发布时间、电话会拨入方式和公司简介，不含业绩、指引、订单或任何会改变盈利预期的信息，不存在方向性催化或预期差，当下无正期望交易。
📄 原文CDNA↗ 原文
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in t…
不做 CareDx, Inc.（CDNA.US）
纯财报日程预告，无收入/利润/指引等任何增量信息，无预期差与方向性 edge；交易机会在2026-10-29盘后实际财报，当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
CareDx 仅通知10月29日盘后发财报，无任何财务或经营增量，属程序性日程公告；不构成事件驱动交易，等实际财报发布再研判。
🔎 新鲜度:最早出现 2026-10-15 · 扩散 low · price-in 风险 low ↗
主要风险
- 真正的波动事件是2026-10-29盘后的三季报及电话会指引，在数据出来前任何方向性仓位都缺乏依据。
先例如何影响了这次决策
对本次决策的影响:确认不交易；待10月29日实际财报再做事件研究与方向判断。
方向:财报日期预告本身历史上不产生方向性反应，真正的价格事件是随后的实际财报，故不就本通知检索先例。
涨幅量级:无对齐先例，也无幅度可校准；本通知不含任何数字。
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`caredx cdna third quarter 2026 financial results date announcement october 29 earnings webcast | caredx q3 2026 earnings release date conference call`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是
原文全文
展开原文 · 1,187 字
BRISBANE, Calif.--(BUSINESS WIRE)--
CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report financial results for the third quarter 2026 after market close on Thursday, October 29, 2026. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET.
A live and archived webcast of the conference call can be accessed on the Events & Presentations section of CareDx’s Investor Relations website at
investors.caredx.com
. To participate in the live conference call via telephone, register
here
. Upon registering, a dial-in number and unique PIN will be provided.
About CareDx
CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, CareDx is dedicated to improving patient outcomes. For more information, please visit
www.caredx.com
.
CareDx
Media Contacts
Natasha Moshirian Wagner
nwagner@caredx.com
Investor Relations
Nina Deka
investor@caredx.com
Source: CareDx, Inc.
CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report financial results for the third quarter 2026 after market close on Thursday, October 29, 2026. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET.
A live and archived webcast of the conference call can be accessed on the Events & Presentations section of CareDx’s Investor Relations website at
investors.caredx.com
. To participate in the live conference call via telephone, register
here
. Upon registering, a dial-in number and unique PIN will be provided.
About CareDx
CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, CareDx is dedicated to improving patient outcomes. For more information, please visit
www.caredx.com
.
CareDx
Media Contacts
Natasha Moshirian Wagner
nwagner@caredx.com
Investor Relations
Nina Deka
investor@caredx.com
Source: CareDx, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
e9dfbdfa4d· 2026-10-16 04:09 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前